Suppr超能文献

急性心肌梗死非理想直接血管成形术的长期预后影响

Long-term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction.

作者信息

Parodi Guido, Valenti Renato, Carrabba Nazario, Memisha Gentian, Moschi Guia, Migliorini Angela, Antoniucci David

机构信息

Division of Cardiology, Careggi Hospital, Florence, Italy.

出版信息

Catheter Cardiovasc Interv. 2006 Jul;68(1):50-5. doi: 10.1002/ccd.20729.

Abstract

AIM

To evaluate the long-term outcome of a nonoptimal result of a primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI).

METHODS AND RESULTS

An optimal PCI result was defined as TIMI flow grade 3 and residual stenosis < or = 20%. Long-term clinical follow-up (51 +/-+/- 21 months) data were collected from 1,009 consecutive patients with ST-elevation AMI who underwent primary PCI. Overall, an optimal primary PCI result was achieved in 958 patients (95%). At 5-year follow-up, patients with nonoptimal PCI had a higher rate of all-cause mortality (47% vs 19%; P < 0.00001 by log-rank test) than those with an optimal mechanical reperfusion. Fifty-two percent of the deaths in the nonoptimal PCI group occurred within the first month. Interestingly, after this period, estimated survival of 30-day alive patients was not significantly different to that of patients with an optimal PCI (P = 0.06 by log-rank test). Nonoptimal PCI result emerged as an independent predictor of 1-month mortality (OR = 3.030, 95% CI = 1.265-7.254; P = 0.013), but not of 5-year mortality. At long-term follow-up, cumulative rates of nonfatal reinfarction, hospitalization for heart failure, and additional revascularization procedures were similar between patients with nonoptimal and optimal primary PCI (4% vs 5%, P = 0.695; 4% vs 5%, P = 921; and 22% vs 20%, P = 0.816, respectively).

CONCLUSION

A nonoptimal primary PCI result represents a strong predictor of early mortality. However, in patients surviving the early phase, the incidence of clinical events at long-term follow-up seems to be similar to successfully reperfused AMI patients.

摘要

目的

评估急性心肌梗死(AMI)患者接受直接经皮冠状动脉介入治疗(PCI)后效果未达最佳的长期预后。

方法与结果

PCI效果最佳定义为心肌梗死溶栓试验(TIMI)血流3级且残余狭窄≤20%。收集1009例接受直接PCI的ST段抬高型AMI连续患者的长期临床随访(51±21个月)数据。总体而言,958例患者(95%)PCI效果最佳。在5年随访时,PCI效果未达最佳的患者全因死亡率高于机械再灌注效果最佳的患者(47%对19%;对数秩检验P<0.00001)。PCI效果未达最佳组52%的死亡发生在第一个月内。有趣的是,在此期间之后,30天存活患者的预计生存率与PCI效果最佳的患者无显著差异(对数秩检验P=0.06)。PCI效果未达最佳是1个月死亡率的独立预测因素(OR=3.030,95%CI=1.265-7.254;P=0.013),但不是5年死亡率的独立预测因素。在长期随访中,PCI效果未达最佳和最佳的患者非致死性再梗死、因心力衰竭住院及再次血运重建治疗的累积发生率相似(分别为4%对5%,P=0.695;4%对5%,P=0.921;22%对20%,P=0.816)。

结论

PCI效果未达最佳是早期死亡率的有力预测因素。然而,在度过早期阶段存活下来的患者中,长期随访时临床事件的发生率似乎与成功再灌注的AMI患者相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验